Vitrolife AB (publ)
VTRLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,609 | $3,512 | $3,234 | $1,681 |
| % Growth | 2.8% | 8.6% | 92.4% | – |
| Cost of Goods Sold | $1,470 | $1,534 | $1,454 | $635 |
| Gross Profit | $2,139 | $1,978 | $1,780 | $1,046 |
| % Margin | 59.3% | 56.3% | 55% | 62.2% |
| R&D Expenses | $117 | $228 | $143 | $114 |
| G&A Expenses | $478 | $433 | $400 | $259 |
| SG&A Expenses | $1,232 | $1,117 | $1,002 | $504 |
| Sales & Mktg Exp. | $754 | $684 | $602 | $244 |
| Other Operating Expenses | $7 | $4,222 | $0 | $0 |
| Operating Expenses | $1,356 | $5,567 | $1,145 | $620 |
| Operating Income | $783 | -$3,589 | $654 | $435 |
| % Margin | 21.7% | -102.2% | 20.2% | 25.9% |
| Other Income/Exp. Net | -$109 | -$123 | -$117 | $25 |
| Pre-Tax Income | $674 | -$3,712 | $537 | $460 |
| Tax Expense | $160 | $139 | $143 | $116 |
| Net Income | $513 | -$3,851 | $394 | $341 |
| % Margin | 14.2% | -109.7% | 12.2% | 20.3% |
| EPS | 3.79 | -28.44 | 2.91 | 2.97 |
| % Growth | 113.3% | -1,077.3% | -2% | – |
| EPS Diluted | 3.78 | -28.44 | 2.91 | 2.97 |
| Weighted Avg Shares Out | 135 | 135 | 135 | 115 |
| Weighted Avg Shares Out Dil | 136 | 135 | 135 | 115 |
| Supplemental Information | – | – | – | – |
| Interest Income | $24 | $12 | $2 | $1 |
| Interest Expense | $98 | $94 | $44 | $10 |
| Depreciation & Amortization | $376 | $425 | $396 | $109 |
| EBITDA | $1,159 | -$3,193 | $977 | $579 |
| % Margin | 32.1% | -90.9% | 30.2% | 34.4% |